基本信息
views: 15
![](https://originalfileserver.aminer.cn/sys/aminer/icon/show-trajectory.png)
Bio
Reid Rubsamen M.D. is a Board Certified anesthesiologist having received his medical training at Pacific Medical Center, San Francisco and Massachusetts General Hospital where in 1989 he served as Chief Resident in Anesthesia.
He was also an NIH funded postdoctoral fellow in the Computer Science department at the Massachusetts Institute of Technology for two years, leaving in 1990 to found Aradigm Corporation. He left Aradigm in 2000 to found Flow Pharma.
Dr. Rubsamen holds an A.B. in Biochemistry and Computer Science from the University of California, Berkeley, an M.S. in Computer Science and an M.D. from Stanford University, and a Masters in Healthcare Management from the Harvard School of Public Health.
Dr. Rubsamen is currently a Clinical Associate Professor at the Case Western Reserve University School of Medicine. He is a named inventor of more than 70 issued U.S. patents, and has over 11,000 citations to his collective work.
Research Interests
Papers共 109 篇Author StatisticsCo-AuthorSimilar Experts
By YearBy Citation主题筛选期刊级别筛选合作者筛选合作机构筛选
时间
引用量
主题
期刊级别
合作者
合作机构
Innovation Anesthesiologypp.227-246, (2024)
Reid M. Rubsamen, Andrew E. Sloan
VACCINESno. 3 (2024): 322
Current Breast Cancer Reportspp.1-14, (2024)
Sharon Wright, Scott R Burkholtz, Cathy Zelinsky, Connor Wittman,Richard T Carback,Paul E Harris,Tikoes Blankenberg,Charles V Herst,Reid M Rubsamen
International journal of molecular sciencesno. 14 (2023): 11827
Load More
Author Statistics
#Papers: 107
#Citation: 5503
H-Index: 45
G-Index: 73
Sociability: 6
Diversity: 0
Activity: 0
Co-Author
Co-Institution
D-Core
- 合作者
- 学生
- 导师
Data Disclaimer
The page data are from open Internet sources, cooperative publishers and automatic analysis results through AI technology. We do not make any commitments and guarantees for the validity, accuracy, correctness, reliability, completeness and timeliness of the page data. If you have any questions, please contact us by email: report@aminer.cn